Niranjan Damle has been elevated to Senior Director – Global Portfolio & Marketing (Pharmaceuticals) at Baxter International Inc., marking an important milestone in his more than 13-year association with the company. In this global leadership role, he is responsible for guiding portfolio strategy and advancing marketing excellence across Baxter’s pharmaceuticals business, with an emphasis on value creation, lifecycle management, and sustainable growth across multiple international markets.
Before stepping into this position, Niranjan served as Director – Marketing, Growth & Emerging Markets & Japan, where he played a central role in shaping expansion strategies across high-growth and strategically important regions. His career at Baxter reflects steady progression through increasingly global and complex mandates. Over the years, he has held leadership roles including Associate Director / Senior Marketing Manager – Pharmaceuticals, Senior Marketing Manager – OUS Pharma Portfolio (Americas), and Marketing Manager – Western Europe Pharmaceuticals, building broad exposure across geographies and healthcare market dynamics.
Earlier in his Baxter journey, Niranjan managed a $100 million global portfolio in his role as Global Marketing Manager. In addition to portfolio leadership, he contributed to initiatives focused on operational excellence and global supply chain strategy, strengthening the commercial and execution backbone of the pharmaceuticals business.
His professional foundation includes research experience as a Graduate Research Assistant at the Rochester Institute of Technology, which helped shape a data-driven, analytical approach that continues to inform his leadership style. Across roles, Niranjan has consistently combined strategic thinking with execution rigor, supporting portfolio growth and market development in both mature and emerging regions.
Niranjan’s elevation reflects Baxter’s confidence in his ability to lead at scale, navigate complex global markets, and drive long-term value creation across its pharmaceuticals portfolio.
 at Baxter International...){kind=link}